Adams Clinical Acquires InSite Clinical Research
December 11, 2024
Adams Clinical has agreed to acquire InSite Clinical Research, a Dallas–Fort Worth clinical trial site specializing in inpatient and outpatient psychiatric and neurologic trials, expanding Adams' capabilities into inpatient psychiatry and Schizophrenia trials. The deal adds a Texas footprint for Adams and follows Adams' broader 2024 expansion; InTandem Capital Partners (Adams' investor) commented on the partnership.
- Buyers
- Adams Clinical, InTandem Capital Partners
- Targets
- InSite Clinical Research
- Platforms
- Adams Clinical
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.